A phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)

Journal article

Peer reviewed

D.P. Petrylak, U.N. Vaishampayan, K.R. Patel, C.S. Higano, C. Albany, N.A. Dawson, B.A. Mehlhaff, D.I. Quinn, L.T. Nordquist, V.J. Wagner, …

Annals of oncology, Vol.30, pp.v340-v341

10/2019

Files and links (1)

url

https://doi.org/10.1093/annonc/mdz248.027View

Published (Version of record) Open

1 Record Views

Title: A phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)
Creators: D.P. Petrylak
U.N. Vaishampayan
K.R. Patel
C.S. Higano
C. Albany
N.A. Dawson
B.A. Mehlhaff
D.I. Quinn
L.T. Nordquist
V.J. Wagner
J. Shen
L. Trandafir
O. Sartor
Publication Details: Annals of oncology, Vol.30, pp.v340-v341
Identifiers: 991006262537002656
Academic Unit: Radiology
Language: English
Resource Type: Journal article